New symptoms, conditions may develop after positive test for SARS-CoV-2
Feb 11, 2022
Among hospitalized patients aged 20 years or older, the prevalence of new fatigue and type 2 diabetes were up for those with a positive versus a negative SARS-CoV-2 result.
Type 2 diabetes tied to accelerated brain aging, cognitive decline
Jun 08, 2022
The authors say the neurological impact may start before diabetes is formally diagnosed.
Height may impact risk for disease
Jun 03, 2022
Novel associations were seen for venous circulatory disorders and peripheral neuropathy in the presence and absence of diabetes.
Subjective cognitive impairment linked to MACE in T2DM
Apr 26, 2022
Among individuals with type 2 diabetes, a country-standardized cognitive score may predict risk for cardiovascular events.
Muscle strengthening may cut risk for noncommunicable disease
Mar 01, 2022
Muscle-strengthening activities were inversely linked to risks for all-cause mortality and major noncommunicable diseases.
Alendronate may reduce risk for type 2 diabetes
Sep 28, 2021
The adjusted odds ratio for type 2 diabetes was further reduced for those with more than eight years of alendronate use.
Antidepressant use may aid outcomes in depression and diabetes
Jul 23, 2021
Regular versus poor antidepressant use was tied to a lower risk for advanced diabetic complications and mortality in patients with depression and diabetes.
Medication type for diabetes may affect severe COVID-19 outcomes
Jun 30, 2021
Premorbid GLP1-RA use, SGLT2i use were associated with lower 60-day mortality compared to premorbid DPP4i use.
ADA: Diabetes may quadruple risk for long COVID
Jun 08, 2022
The authors say that the review findings are limited by heterogenous definitions of long COVID in published studies.
Add-on PPI therapy may improve glycemic control in diabetes
Jun 28, 2021
Treatment with proton pump inhibitors, however, is not associated with risk for incident diabetes in the general population.